|4Jan 3, 6:32 PM ET

Rewcastle John Cameron 4

4 · Enox Biopharma Inc · Filed Jan 3, 2011

Insider Transaction Report

Form 4
Period: 2011-01-01
Rewcastle John Cameron
Chief Executive Officer
Transactions
  • Purchase

    Employee Option

    2011-01-01+1,327,2921,327,292 total
    Exercise: $0.90From: 2013-01-01Exp: 2021-01-01Common Stock (1,327,292 underlying)
Footnotes (1)
  • [F1]one-third vest on each of the first three anniversaries of employment.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT